Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Integra Lifesciences Holdings Corp shares valued at $100,102 were sold by Schwartz Eric on Dec 03 ’24. At $24.59 per share, Schwartz Eric sold 4,070 shares. The insider’s holdings dropped to 59,511 shares worth approximately $1.32 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Schwartz Eric purchased 4,070 shares, netting a total of over 100,102 in proceeds.
Before that, McBreen Michael J. had sold 1,700 shares from its account. In a trade valued at $41,064, the EVP & President, CSS traded Integra Lifesciences Holdings Corp shares for $24.16 each. Upon closing the transaction, the insider’s holdings decreased to 1,700 shares, worth approximately $1.24 million.
As published in their initiating research note from Morgan Stanley on December 02, 2024, Integra Lifesciences Holdings Corp [IART] has been an Underweight and the price target has been revised to $20. Analysts at BTIG Research upgraded the stock from ‘”a Sell”‘ to ‘”a Neutral”‘ outlook in a report released in early October. As of July 30, 2024, Citigroup has decreased its “Neutral” rating to a “Sell” for IART. Earlier on July 30, 2024, BTIG Research downgraded its rating. Their new recommendation was “a Sell” for IART stock which previously was a “a Neutral”.
Analyzing IART Stock Performance
During the last five days, there has been a drop of approximately -8.24%. Over the course of the year, Integra Lifesciences Holdings Corp shares have dropped approximately -49.12%. Shares of the company reached a 52-week high of $45.42 on 02/20/24 and a 52-week low of $16.81 on 10/03/24. A 50-day SMA is recorded $22.31, while a 200-day SMA reached $25.83. Nevertheless, trading volume fell to 0.68 million shares from 0.66 million shares the previous day.
Support And Resistance Levels for Integra Lifesciences Holdings Corp (IART)
According to the 24-hour chart, there is a support level at 21.75, which, if violated, would cause prices to drop to 21.35. In the upper region, resistance lies at 22.91. The next price resistance is at 23.67. RSI (Relative Strength Index) is 39.15 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.00, which suggests the price will decrease in the coming days. Percent R is at 97.92%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
